Title : Cyclophosphamide as second-line therapy in multiple sclerosis: benefits and risks.

Pub. Date : 2009 Oct

PMID : 19882369






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 As second-line therapy, Cy can be used in non-responders to IFN-beta or glatiramer acetate. Cyclophosphamide interferon beta 1 Homo sapiens